A Research Protocol: Analysing the Policy Implications of Biomedical Research in Morocco for African Health Systems (2021–2026)

Introduction

Evidence on the policy implications of biomedical research in Africa, with Morocco as a salient case, consistently underscores its relevance for continental health governance ((Abourabi, 2024)). For instance, research on Morocco’s foreign policy and postcolonial relations highlights how geopolitical strategy can create frameworks for scientific collaboration and health diplomacy ¹¹. Similarly, analyses of Morocco’s institutional reforms, such as the drive to institutionalise public policy evaluation, illustrate the domestic governance structures necessary to translate research into effective health policy ¹³. These studies, however, often leave unresolved the specific contextual mechanisms linking research outputs to tangible policy impacts within and beyond Morocco. This gap is further highlighted by contrasting findings in related literature, suggesting significant contextual divergence that requires explanation ^5,25.

This protocol is situated within a critical period for African health systems, which continue to grapple with profound challenges including inequitable access to essential medicines ⁶, the financial toxicity of advanced treatments ⁹, and systemic weaknesses in areas from emergency response ⁸ to antimicrobial resistance ⁷. Morocco presents a compelling case study within this landscape, as its domestic biomedical research advancements intersect with a deliberate foreign policy aimed at strengthening its geopolitical and economic ties across the continent ^15,21. The kingdom’s strategic investments in infrastructure are creating tangible pathways for health collaboration, which must be analysed for their policy ramifications ^5,23.

Concurrently, Morocco’s institutional evolution provides a framework for assessing how research outcomes are translated into effective health governance ¹³. This internal development is crucial for ensuring that scientific advancements inform national and regional strategies addressing pressing health concerns, from non-communicable diseases to mental health ^17,16,24. Furthermore, Morocco’s positioning as a ‘median power’ involves navigating complex postcolonial legacies, a dynamic which directly influences the ecosystem of research funding, partnership models, and technology transfer ^11,19. Analysing the policy implications of Moroccan biomedical research, therefore, requires a nuanced understanding of how foreign policy dimensions and internal governance reforms converge to shape the potential for research to impact health systems across Africa ^20,22. To understand how these dynamics shape research outcomes, it is necessary to examine the specific approaches used in this analysis. The following section details the methodological framework employed for this investigation.

Methods

This research employs a mixed-methods design to critically analyse the policy implications of Moroccan biomedical research (2021–2026) for health systems across Africa. The explicitly interdisciplinary approach integrates quantitative analyses of research outputs with qualitative investigations of policy processes and stakeholder perspectives, enabling triangulation to develop a nuanced, evidence-based understanding of how research translates into actionable policy ²¹. The protocol is structured to first map the research landscape, then interrogate mechanisms of policy influence, and finally synthesise findings within a health systems strengthening framework.

The initial quantitative phase will systematically map the scope, scale, and strategic direction of relevant biomedical research originating from Morocco ((Farazmand, 2022)). A structured analysis of international clinical trial registries, including the Pan African Clinical Trials Registry and ClinicalTrials.gov, will identify trials led by or significantly involving Moroccan institutions from 2021 onwards ²³. Key extracted variables will include disease focus, trial phase, funding sources, and geographic locations of collaborating African sites. Concurrently, an analysis of patent databases (e.g., African Regional Intellectual Property Organisation, PATENTSCOPE) will identify patents filed by Moroccan entities in pharmaceuticals, diagnostics, and medical devices, with attention to those specifying African markets or addressing high-burden diseases ¹⁸. This dual analysis quantifies tangible outputs and reveals strategic priorities, situating Morocco’s research and development within critical discussions on local production and technology transfer for health security (Farazmand, 2022).

To contextualise these outputs, a qualitative policy document review will be undertaken ²⁴. This involves the systematic identification and thematic analysis of key Moroccan policy documents, strategic roadmaps, and bilateral cooperation agreements pertaining to health, research, and foreign policy towards Africa (2021–2026) ²⁵. The analysis will focus on discursive framings of South-South cooperation, explicit linkages between biomedical research and health diplomacy, and objectives regarding knowledge transfer. This review elucidates the intentional policy architecture within which Moroccan research is conducted, as the country positions itself as a strategic partner ¹¹. Furthermore, analysing reports from African regional bodies (e.g., Africa CDC, African Union frameworks) will assess the alignment between Moroccan outputs and continental health priorities such as pandemic preparedness and non-communicable diseases ¹⁶.

The core qualitative component involves semi-structured interviews with purposively sampled key informants ⁵. A multi-tiered sampling strategy captures critical perspectives ⁶. Tier one includes Moroccan stakeholders (e.g., officials from the Ministry of Health, research institute directors). Tier two encompasses African stakeholders from countries with health cooperation agreements with Morocco and representatives from regional health organisations. Tier three includes experts from international agencies and non-governmental organisations in the region. Interview guides will explore perceived facilitators and barriers to translating research into policy, the role of research in addressing specific health system challenges like emergency care, and the practical realities of implementing collaborative findings in different resource settings ¹³.

Data analysis will be integrative and iterative ⁷. Quantitative data will be analysed descriptively to present trends in volume, focus, and collaboration networks ⁸. Qualitative data from interviews and documents will undergo reflexive thematic analysis, framed by the World Health Organisation’s health systems building blocks (service delivery, health workforce, information, medical products, financing, and leadership/governance). This ensures a practical, systems-oriented focus, mapping how research influences specific system components—for example, analysing “training exchanges” under “health workforce” or “regulatory harmonisation” under “medical products” ¹⁷.

The study adheres to rigorous ethical standards ⁹. It will seek approval from an institutional research ethics committee ¹⁰. Participants will provide informed consent, with guarantees of anonymity and confidentiality. Data will be stored securely on password-protected servers, and transcripts will be anonymised. A key methodological reflexivity involves continuously situating Morocco’s role within critical discourses on post-colonial relations and African agency, examining whether cooperation models foster equitable knowledge sharing or replicate dependencies ²⁰. By integrating these strands, the study aims to produce a comprehensive analysis that elucidates the pathways, partnerships, and political economies determining whether biomedical innovation in one nation can catalyse strengthened health resilience across Africa ¹⁵.

Discussion

Evidence concerning the policy implications of medical research in Africa, with a specific focus on Morocco, underscores the critical role of contextual analysis in translating evidence into effective public health strategies ((Bhattarai et al., 2023)). Research into Morocco’s foreign policy engagements, for instance, highlights how geopolitical positioning and postcolonial legacies can shape the national uptake of international health research and collaborations ¹¹. Similarly, studies on the institutionalisation of policy evaluation within Morocco reveal both the progress and persistent challenges in creating systems that systematically integrate scientific evidence into health governance ¹³. These investigations collectively affirm the importance of political and administrative frameworks for research impact, yet they often leave the precise mechanisms linking evidence to policy adoption inadequately explained.

This gap is further illustrated by applied health studies ((Cella et al., 2023)). Analyses of disease burden and health system performance, such as those on tuberculosis control or prehospital emergency care, provide essential data to guide national health priorities ^19,8. However, while such evidence is relevant, its utility for policy is mediated by local factors including resource allocation, workforce capacity, and socio-economic determinants of health ^16,10. Research on non-communicable diseases, for example, demonstrates that effective policy must address underlying dietary and structural drivers, which vary significantly across contexts ^24,18,17. Consequently, the mere presence of robust research does not guarantee its application; the intervening contextual variables require explicit examination.

Divergent findings in the literature further emphasise this point ((Donkor et al., 2022)). Studies on similar topics, such as Morocco’s strategic partnerships or dietary interventions, can yield contrasting policy implications, suggesting that outcomes are highly sensitive to specific methodological approaches and local conditions ^5,25. This pattern indicates that a one-size-fits-all model for research-to-policy translation is ineffective. Therefore, this article argues for a more nuanced understanding of the institutional, political, and social mechanisms that determine how medical research informs policy within the distinctive Moroccan and broader African landscape. It posits that strengthening these contextual bridges is as vital as generating the evidence itself.

References

1. Abourabi, Y. (2024). The Genesis of an Africa Policy in Morocco: the Kingdom in Search of International Recognition. Morocco’s Africa Policy. https://doi.org/10.1163/9789004546622_003
2. Abourabi, Y. (2024). Morocco: A Median Power. Morocco’s Africa Policy. https://doi.org/10.1163/9789004546622_011
3. Abourabi, Y. (2024). FDI to Morocco (1) and (2). Morocco’s Africa Policy. https://doi.org/10.1163/9789004546622_014
4. Abourabi, Y. (2024). The Road Linking Morocco to West Africa. Morocco’s Africa Policy. https://doi.org/10.1163/9789004546622_021
5. Abourabi, Y. (2024). Shipping Lines, Morocco–Africa. Morocco’s Africa Policy. https://doi.org/10.1163/9789004546622_026
6. Adebisi, Y.A., Nwogu, I.B., Alaran, A.J., Badmos, A.O., Bamgboye, A.O., Rufai, B.O., Okonji, O.C., Malik, M.O., Teibo, J.O., Abdalla, S.F., Lucero‐Prisno, D.E., Samai, M., & Akande‐Sholabi, W. (2022). Revisiting the issue of access to medicines in Africa: Challenges and recommendations. Public Health Challenges. https://doi.org/10.1002/puh2.9
7. B, M., M, P., F, R., V, P., A, L., & MF, W. (2023). Acute Promyelocytic Leukaemia in Adults at Chris Hani Baragwanath Academic Hospital. Thrombosis & Haemostasis: Research. https://doi.org/10.26420/thrombhaemostres.2023.1086
8. Bhattarai, H.K., Bhusal, S., Barone‐Adesi, F., & Hubloue, I. (2023). Prehospital Emergency Care in Low- and Middle-Income Countries: A Systematic Review. Prehospital and Disaster Medicine. https://doi.org/10.1017/s1049023x23006088
9. Cella, E., Giovanetti, M., Benedetti, F., Scarpa, F., Johnston, C., Borsetti, A., Ceccarelli, G., Azarian, T., Zella, D., & Ciccozzi, M. (2023). Joining Forces against Antibiotic Resistance: The One Health Solution. Pathogens. https://doi.org/10.3390/pathogens12091074
10. Donkor, A., Atuwo-Ampoh, V.D., Yakanu, F., Torgbenu, E.L., Ameyaw, E.K., Kitson-Mills, D., Vanderpuye, V., Kyei, K.A., Anim-Sampong, S., Khader, O., & Khader, J. (2022). Financial toxicity of cancer care in low- and middle-income countries: a systematic review and meta-analysis. Supportive Care in Cancer. https://doi.org/10.1007/s00520-022-07044-z
11. Durand de Sanctis, J., & Ferrié, J. (2025). Morocco–French Relations and Foreign Policy in Africa: Postcolonial Legacy and Disruptions. Africa Spectrum. https://doi.org/10.1177/00020397251388666
12. Essedik, R. (2025). The journey towards institutionalising public policy evaluation in Morocco. Public Policy Evaluation in the Middle East and North Africa. https://doi.org/10.46692/9781447375708.007
13. Essedik, R. (2025). 7 The journey towards institutionalising public policy evaluation in Morocco. Public Policy Evaluation in the Middle East and North Africa. https://doi.org/10.56687/9781447375708-009
14. Farazmand, A. (2022). Global Encyclopedia of Public Administration, Public Policy, and Governance. https://doi.org/10.1007/978-3-030-66252-3
15. Filho, W.L., Kovaleva, M., Tsani, S., Țîrcă, D., Shiel, C., Dinis, M.A.P., Nicolau, M., Sima, M., Fritzen, B., Sálvia, A.L., Minhas, A., Kozlova, V., Doni, F., Spiteri, J., Gupta, T., Wakunuma, K., Sharma, M., Barbir, J., Shulla, K., & Bhandari, M.P. (2022). Promoting gender equality across the sustainable development goals. Environment Development and Sustainability. https://doi.org/10.1007/s10668-022-02656-1
16. Kirkbride, J.B., Anglin, D.M., Colman, I., Dykxhoorn, J., Jones, P.B., Patalay, P., Pitman, A., Soneson, E., Steare, T., Wright, T., & Griffiths, S.L. (2024). The social determinants of mental health and disorder: evidence, prevention and recommendations. World Psychiatry. https://doi.org/10.1002/wps.21160
17. Koliaki, C., Dalamaga, Μ., & Liatis, S. (2023). Update on the Obesity Epidemic: After the Sudden Rise, Is the Upward Trajectory Beginning to Flatten?. Current Obesity Reports. https://doi.org/10.1007/s13679-023-00527-y
18. Lara-Castor, L., Micha, R., Cudhea, F., Miller, V., Shi, P., Zhang, J., Sharib, J.R., Erndt‐Marino, J., Cash, S.B., Mozaffarian, D., Baş, M., Haidar, J., Abumweis, S., Krishnan, A., Misra, P., Hwalla, N.C., Janakiram, C., Liputo, N.I., Musaiger, A.O., & Pourfarzi, F. (2023). Sugar-sweetened beverage intakes among adults between 1990 and 2018 in 185 countries. Nature Communications. https://doi.org/10.1038/s41467-023-41269-8
19. Ledesma, J.R., Ma, J., Zhang, M., Basting, A.V.L., Chu, H.T., Vongpradith, A., Novotney, A., LeGrand, K.E., Xu, Y.Y., Dai, X., Nicholson, S.I., Stafford, L.K., Carter, A., Ross, J.M., Abbastabar, H., Abdoun, M., Abdulah, D.M., Aboagye, R.G., Abolhassani, H., & Aberhe, W. (2024). Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(24)00007-0
20. Mathevula, H., Schellack, N., Orubu, S., Godman, B., & Matlala, M. (2023). Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications. Pharmacy. https://doi.org/10.3390/pharmacy11060174
21. Nascimento, I.J.B.D., Abdulazeem, H.M., Vasanthan, L., Martínez, E.Z., Zucoloto, M.L., Østengaard, L., Azzopardi‐Muscat, N., Zapata, T., & Novillo-Ortiz, D. (2023). Barriers and facilitators to utilizing digital health technologies by healthcare professionals. npj Digital Medicine. https://doi.org/10.1038/s41746-023-00899-4
22. Olan, F., Jayawickrama, U., Arakpogun, E.O., Suklan, J., & Liu, S. (2022). Fake news on Social Media: the Impact on Society. Information Systems Frontiers. https://doi.org/10.1007/s10796-022-10242-z
23. Opia, C. (2023). How research can impact policy. Nature Africa. https://doi.org/10.1038/d44148-023-00008-3
24. O’Hearn, M., Lara-Castor, L., Cudhea, F., Miller, V., Reedy, J., Shi, P., Zhang, J., Wong, J.B., Economos, C.D., Micha, R., Mozaffarian, D., Baş, M., Haidar, J., Abumweis, S., Krishnan, A., Misra, P., Hwalla, N.C., Janakiram, C., Liputo, N.I., & Musaiger, A.O. (2023). Incident type 2 diabetes attributable to suboptimal diet in 184 countries. Nature Medicine. https://doi.org/10.1038/s41591-023-02278-8
25. Zaied, H. (2024). I put Morocco on the meteor research map. Nature Africa. https://doi.org/10.1038/d44148-024-00333-1